Encapsulating Peritoneal Sclerosis in a kidney transplant recipient - Case Report

Abstract

Encapsulating Peritoneal Sclerosis (EPS) is a severe and rare condition frequently associated with peritoneal dialysis, characterized by bowel obstruction, with lethal consequences in 20% of the patients. The disease presents as a mass of fibrous tissue encapsulating visceral organs that may potentially compromise digestive tract function. This report describes the case of a patient under peritoneal dialysis (PD) due to chronic kidney disease secondary to focal segmental glomerulosclerosis diagnosed with EPS. The patient had undergone two living-donor kidney transplant procedures. Surgical techniques and clinical measures employed to unravel bowel obstruction are described, which have been shown to ameliorate EPS secondary complications. Parenteral nutrition has significantly contributed to afford adequate nutrition, improving tissue healing as well as serum protein levels, vitamins and electrolytes. Therapy with tamoxifen and sodium thiosulfate effectively delayed the development of EPS.

Comment on "Encapsulating Peritoneal Sclerosis in a kidney transplant recipient: Case Report"

“…We read with interest the article by Ribeiro et al (2020) 1 , about the Encapsulating Peritoneal Sclerosis (EPS) in subjects on peritoneal dialysis (PD). When exposed to PD dialysis solutions, the peritoneal membrane undergoes some morphological changes.…”